AnazaoHealth Corporation: Drug Recall
Recall #D-0203-2024 · 11/22/2023
Class II: Risk
Recall Details
- Recall Number
- D-0203-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AnazaoHealth Corporation
- Status
- Terminated
- Date Initiated
- 11/22/2023
- Location
- Las Vegas, NV, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,707 vials
Reason for Recall
Presence of Particulate Matter.
Product Description
B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3
Distribution Pattern
Nationwide in the USA.
Other Recalls by AnazaoHealth Corporation
- Class II: Risk 11/22/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.